A Prospective Controlled Trial to Evaluate Safety and Efficacy of in vitro Expanded Recipient Regulatory T Cell Therapy and Tocilizumab Together With Donor Bone Marrow Infusion in HLA-Mismatched Living Donor Kidney Transplant Recipients (Trex001)
Oberbauer, Rainer, Edinger, Matthias, Berlakovich, Gabriela, Kalhs, Peter, Worel, Nina, Heinze, Georg, Wolzt, Michael, Lion, Thomas and Wekerle, Thomas (2021) A Prospective Controlled Trial to Evaluate Safety and Efficacy of in vitro Expanded Recipient Regulatory T Cell Therapy and Tocilizumab Together With Donor Bone Marrow Infusion in HLA-Mismatched Living Donor Kidney Transplant Recipients (Trex001). Frontiers in Medicine 7.Date of publication of this fulltext: 29 Feb 2024 12:27
Article
Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | Frontiers in Medicine | ||||
| Publisher: | Frontiers | ||||
|---|---|---|---|---|---|
| Place of Publication: | LAUSANNE | ||||
| Volume: | 7 | ||||
| Date | 2021 | ||||
| Institutions | Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie) Leibniz Institute for Immunotherapy (LIT) | ||||
| Identification Number |
| ||||
| Keywords | ; kidney transplantation; cell therapy; regulatory T cells; chimerism; tolerance; bone marrow; belatacept; tocilizumab | ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 56345 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric